Your browser doesn't support javascript.
loading
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
Matucci, Andrea; Caminati, Marco; Vivarelli, Emanuele; Vianello, Andrea; Micheletto, Claudio; Menzella, Francesco; Crisafulli, Ernesto; Passalacqua, Giovanni; Bagnasco, Diego; Lombardi, Carlo; Parronchi, Paola; Crivellaro, Mariaangiola A; Chieco-Bianchi, Fulvia; Rita Marchi, Maria; Guarnieri, Gabriella; Cosmi, Lorenzo; Rossi, Oliviero; Almerigogna, Fabio; Senna, Gianenrico; Vultaggio, Alessandra.
Afiliação
  • Matucci A; Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
  • Caminati M; Department of Medicine, Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, Verona, Italy.
  • Vivarelli E; Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
  • Vianello A; Respiratory Pathophysiology Unit, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Italy.
  • Micheletto C; Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Verona, Italy.
  • Menzella F; Department of Medical Specialties, Pneumology Unit, Arcispedale Santa Maria Nuova, Azienda USL di Reggio Emilia-IRCCS, Reggio Emilia, Italy.
  • Crisafulli E; Department of Medicine, Respiratory Medicine Unit and Section of Internal Medicine, University of Verona and Verona University Hospital, Verona, Italy.
  • Passalacqua G; Allergy and respiratory diseases, DIMI Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.
  • Bagnasco D; Allergy and respiratory diseases, DIMI Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino, Genoa, Italy.
  • Lombardi C; Departmental Unit of Allergology, Istituto Ospedaliero "Fondazione Poliambulanza", Brescia, Italy.
  • Parronchi P; Immunology and Cell Therapy Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
  • Crivellaro MA; Allergology Unit - Occupational Medicine, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.
  • Chieco-Bianchi F; Respiratory Pathophysiology Unit, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Italy.
  • Rita Marchi M; UOC Pneumologia Cittadella, Euganea, Italy.
  • Guarnieri G; Respiratory Pathophysiology Unit, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Italy.
  • Cosmi L; Immunology and Cell Therapy Unit, Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.
  • Rossi O; Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
  • Almerigogna F; Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
  • Senna G; Department of Medicine, Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, Verona, Italy.
  • Vultaggio A; Immunoallergology Unit, Careggi University Hospital, Florence, Italy.
Allergy ; 76(3): 871-874, 2021 03.
Article em En | MEDLINE | ID: mdl-32716580
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Produtos Biológicos / SARS-CoV-2 / COVID-19 / Inflamação Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Produtos Biológicos / SARS-CoV-2 / COVID-19 / Inflamação Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article